MPO Movers

MPO’s Most-Read Stories This Week—Aug. 24

A listing of the most popular items from the past seven days.

By: Michael Barbella

Managing Editor

Money matters mattered most to MPO readers this past week. 

Financial-related news drove the majority of website traffic over the past seven days, and ZOLL led the charge by publicizing its winning bid for Vyaire’s ventilator business as part of the firm’s Chapter 11 bankruptcy proceedings. The deal is subject to court approval at a sale hearing and a successful closing is expected in the coming weeks. Vyaire filed for bankruptcy on June 10. 

Johnson & Johnson had the second-highest pageviews, courtesy of its tentative deal to acquire V-Wave, a privately-led company that develops treatment options for patients with heart failure. J&J will acquire V-Wave for a $600 million upfront payment, with potential for further regulatory and commercial milestone payments up to about $1.1 billion. V-Wave will join J&J as part of Johnson & Johnson MedTech. V-Wave’s cardiovascular implant technology targets heart failure with reduced ejection fraction (HFrEF), a condition where the heart muscle cannot sufficiently pump blood-containing oxygen and nutrients to the body. The company’s Ventura interatrial shunt (IAS) decreases elevated left atrial pressure seen in congestive heart failure by creating a shunt between the left and right atrium. 

Genesis MedTech placed third with news that it sold its JC Medical company to Edwards Lifesciences. This includes the intellectual property (IP) and commercial rights for the J-Valve transcatheter aortic valve replacement (TAVR) to treat severe aortic regurgitation. 

Neuspera Medical rounded out the top five news stories with its $23 million Series D funding round, ranking behind an online exclusive about the impact of innovative technologies on medtech manufacturing.

1. ZOLL is Winning Bidder to Acquire Vyaire’s Ventilator Biz

2. J&J MedTech to Acquire V-Wave for up to $1.7 Billion

3. Genesis MedTech Sells JC Medical to Edwards

4. How Innovative Technologies Are Revolutionizing Medical Device Manufacturing

5. Neuspera Medical Closes Series D Funding Round

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters